Advisorshares Vice ETF (ACT)
$24.95
0.21 (0.84%)
16:15 EST
ACT Stock Quote Delayed 15 Minutes
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1,800
Day's Range
24.93 - 24.97
52-Week Range
20.88 - 26.02
Dividend & Yield
0.05 (0.18%)
ACT Stock Predictions, Articles, and Advisorshares Vice ETF News
- From InvestorPlace
- From the Web
3 Marijuana ETFs to Buy for Safer Cannabis-Based Gains
Marijuana stocks could be great long-term investments. However, they are still a risky bet. These marijuana ETFs make owning them a little less dangerous.
7 Consumer Staples ETFs to Buy Now
Despite talk of overvaluation, there are some consumer staples ETFs that can deliver more exciting returns to the normally sleepy sector.
5 Vice ETFs That Are Worth Sinning For
The current crop of vice ETFs include more focused plays, such as funds focusing explicitly on specific vices. For example, today's vice ETFs include a marijuana fund, a gambling ETF and so on.
Here Are the Only Two Marijuana ETFs U.S. Investors Need Consider
The universe of U.S. marijuana ETFs is sparsely populated. Right now, these marijuana ETFs are the only two that U.S. investors need consider.
3 Marijuana ETFs for Everyday Investors to Play the Cannabis Movement
Marijuana ETFs may still be few and far between, but these three are more than enough to get regular investors safely into the game.
3 Marijuana ETFs With Potential to Harvest
Despite their potential for profit, the U.S. has a real lack of marijuana ETFs. Here are 3 funds to get you some marijuana exposure while the market catches up.
3 Marijuana ETFs That Will Have a Huge 2018
In the world of ETFs, the most widely anticipated products are those related to cryptocurrencies and marijuana stocks. Investors will be waiting awhile for digital currency ETFs as regulators recently rebuffed plans for such funds. Fortunately, marijuana ETFs are not encountering the same resistance.
6 ‘Star Wars’ ETFs to Embrace the Light or Dark Side
Some of the best ETFs to buy focus either on the light or dark sides of the market. Here's what investors should know about ETFs that focus on socially responsible stocks and sin stocks.
Hottest Healthcare Stocks Now – VRX FMS STE MDCO
Healthcare stocks remained flat on Thursday morning on Wall Street.
Hottest Healthcare Stocks Now – PTCT EXAS WST EXAM
Healthcare stocks rose broadly on Wall Street today, with the sector seeing an overall increase of 1.2%.
Hottest Healthcare Stocks Now – WMGI ALXN TRNX SGEN
Healthcare stocks finished flat on Thursday on Wall Street.
7 ‘Smart Money’ Investors: The Stocks They Love and the Stocks They Hate
A new batch of 13Fs has given us insight into what Wall Street's "smart money" thought was worth buying and selling in Q1. Here are some of the best ideas from the group.
Biggest Movers in Healthcare Stocks Now – LGND HZNP RGEN MNTA
Healthcare stocks rose 0.2% on Wall Street so far on Monday.
Hottest Healthcare Stocks Now – KND SEM WX LCI
Healthcare stocks rose 1.2% on Wall Street so far on Friday.
Hottest Healthcare Stocks Now – CEMP HZNP GHDX ALXN
Healthcare stocks finished up 0.6% on Wall Street on Monday.
Hottest Healthcare Stocks Now – MYL TEVA PCRX THC
Healthcare stocks finished down broadly on Wall Street today, with the sector seeing an overall decline of 0.9%.
Are Biotech Stocks Set for a Resurgence?
By
Jeff Reeves
After some recent consolidation, biotech stocks could be a buy now that the worst of the washout is over and sentiment is improving.
Hottest Healthcare Stocks Now – THRX EXAM ACT EXAS
Healthcare stocks finished up 0.2% on Wall Street on Tuesday.
ACT: Know Your Actavis Stock Options
Investors in Actavis plc (NYSE:ACT) saw new options begin trading today for the June 19 expiration.
Which Hedge Fund Manager Won Q1?
Andreas Halvorsen's long stock positions as disclosed in Viking Global's latest 13F filing had a solid first quarter as they delivered an average return of 6.2% based on our calculations.
10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!